Acacia Technologies Licenses Two Additional Cable TV Companies; Company Also Adds 7 Internet Licensees and Has Now Signed 169 DMT Technology License Agreements

Business Wire,  August 16, 2004  

Tags: cable, Internet

• E-mail
• Print
• Link

NEWPORT BEACH, Calif. -- Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that its Acacia Technologies group, a technology licensing company, has entered into two additional license agreements for its Digital Media Transmission ("DMT") technology in the cable television industry.

Paul Ryan, Chairman and Chief Executive Officer, commented, "We are pleased that we are making progress in licensing our DMT(R) technology to the cable TV industry. Acacia Technologies has now signed license agreements with four cable companies in the last six weeks."

The licenses to Seren Innovations, Inc. and Boulder Ridge Cable TV resolve a patent infringement lawsuit filed by Acacia on June 15, 2004 against the two companies, which were pending in the District Court for the Northern District of California.

Rob Berman, Executive Vice President and General Counsel stated, "We continue to gain momentum in licensing the cable TV industry. We are also expanding our base of Internet licensees, including seven in the last two weeks and fifteen in the past four weeks."

Acacia has entered into 169 license agreements for its DMT(R) technology for cable TV, corporate websites, e-learning, hotel on-demand TV services, and online entertainment, movies, music, news, and sports.

Earlier this quarter, the Company executed on its strategy of acquiring additional patents by acquiring a patent that covers technology and methods for redirecting users to login pages when accessing the Internet and has potential licensing opportunities, which include wireless "hotspots" and hotel high-speed Internet access.

About Acacia Research Coporation

Acacia Research Corporation comprises two operating groups, Acacia Technologies group and CombiMatrix group.

The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia's DMT(R) technology, which is supported by 5 U.S. and 31 foreign patents, relates to audio and audio/video transmission and receiving systems commonly known as audio-on-demand, video-on-demand, and audio/video streaming, and is used for distributing digital content via several means including Internet, cable, satellite and wireless systems.

The CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications including DNA synthesis/diagnostics, drug discovery, and immunochemical detection. CombiMatrix's Express Track(SM) drug discovery program is a systems biology approach, using its technology, to target common viral diseases with siRNA compounds.

Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.

Information about the Acacia Technologies group and the CombiMatrix group is available at www.acaciaresearch.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K, recent and forthcoming Quarterly Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

COPYRIGHT 2004 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning